 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || GSK4172239 / GSK
Enrollment open, Trial initiation date: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years (clinicaltrials.gov) - Sep 8, 2023
P1, N=40, Recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting | Initiation date: Feb 2023 --> Aug 2023
- || GSK4172239 / GSK
New P1 trial: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years (clinicaltrials.gov) - Dec 21, 2022
P1, N=40, Not yet recruiting, Sponsor: GlaxoSmithKline